Ovarian cancer staging: Does it require a gynecologic oncologist?
Open Access
- 1 November 1992
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 47 (2), 223-227
- https://doi.org/10.1016/0090-8258(92)90110-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyGynecologic Oncology, 1991
- Cancer statistics, 1991CA: A Cancer Journal for Clinicians, 1991
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Chemotherapy Consisting of Cisplatin, Doxorubicin, and Cyclophosphamide as an Adjunct to Surgery in Stage Ic-II Epithelial Ovarian CarcinomaAmerican Journal of Clinical Oncology, 1989
- Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.Journal of Clinical Oncology, 1988
- Postoperative abdominopelvic radiation therapy for ovarian cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Staging laparotomy in early epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- A review of second-look laparotomy for ovarian cancerGynecologic Oncology, 1986
- Optimal surgical therapy in stage I and II ovarian malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Ovarian carcinoma metastatic to the diaphragm—frequently undiagnosed at laparotomyAmerican Journal of Obstetrics and Gynecology, 1973